CIBC Capital Markets raised its price target on WELL Health Technologies Corp. (WELL.TO) to $5.25 from $5.
Analyst Scott Fletcher maintained a Neutral rating on shares of the Vancouver-based digital health technology and outpatient clinic company.
"WELL provided an update on its Canadian clinical business, as it continues to acquire additional clinics and drive cost savings in the clinical business," Fletcher said in a note to clients.
"Of WELL's portfolio, we remain most interested in WELL's Canadian assets, both on the clinical and digital side," the analyst said.
"US asset sales, and the clarity they would bring to the story, are the likely next catalyst for WELL, but timing of sales remains uncertain given the accounting issues at Circle Medical and the lack of viable offers for WISP received to date."
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.